鈴木 栄治

最終更新日時: 2020/02/07 15:59:40

印刷する

氏名(漢字／フリガナ／アルファベット表記)
鈴木 栄治／スズキ エイジ／Suzuki, Eizi
所属部署・職名(部局／所属／講座等／職名)
医学研究科／医学専攻外科学講座乳腺外科学／准教授
学部兼担
部局 所属 講座等 職名
医学部
学内兼務
部局 所属 講座等 職名
医学研究科 医学研究科 医学専攻
連絡先住所
種別 住所(日本語) 住所(英語)
職場 京都市左京区聖護院川原町54 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, Japan
連絡先電話番号
種別 番号
職場 075-751-3660
所属学会(国内)
学会名(日本語) 学会名(英語)
日本外科学会
日本乳癌学会
日本乳房オンコプラスティックサージェリー学会
日本癌治療学会
所属学会(海外)
学会名(英語) 国名
American Association for Cancer Research
American Society of Clinical Oncology
American Society of Breast Surgeons
取得学位
学位名(日本語) 学位名(英語) 大学(日本語) 大学(英語) 取得区分
博士（医学） 岡山大学
researchmap URL
https://researchmap.jp/7000009073
研究テーマ
(日本語)
腫瘍微小環境における免疫細胞の役割
(英語)
A role of immune cells in tumor microenvironment
研究分野（キーワード）
キーワード(日本語) キーワード(英語)
腫瘍免疫 Tumor Immunity
論文
著者 著者(日本語) 著者(英語) タイトル タイトル(日本語) タイトル(英語) 書誌情報等 書誌情報等(日本語) 書誌情報等(英語) 出版年月 査読の有無 記述言語 掲載種別 公開
Masuda N, Ohtani S, Takano T, Inoue K, Suzuki E, Nakamura R, Bando H, Ito Y, Ishida K, Yamanaka T, Kuroi K, Yasojima H, Kasai H, Takakusa T, Sakurai T, Kataoka T, Morita S, Ohno S, Toi M Masuda N, Ohtani S, Takano T, Inoue K, Suzuki E, Nakamura R, Bando H, Ito Y, Ishida K, Yamanaka T, Kuroi K, Yasojima H, Kasai H, Takakusa T, Sakurai T, Kataoka T, Morita S, Ohno S, Toi M Eizi Suzuki A randomized, 3 arm, neoadjuvant, phase 2 study comparing docetaxel+carboplatin+trastuzumab+pertuzumab (TCbHP), TCbHP followed by trastuzumab emtansine and pertuzumab (T DM1+P), and T DM1+P in HER2 positive primary breast cancer A randomized, 3 arm, neoadjuvant, phase 2 study comparing docetaxel+carboplatin+trastuzumab+pertuzumab (TCbHP), TCbHP followed by trastuzumab emtansine and pertuzumab (T DM1+P), and T DM1+P in HER2 positive primary breast cancer A randomized, 3 arm, neoadjuvant, phase 2 study comparing docetaxel+carboplatin+trastuzumab+pertuzumab (TCbHP), TCbHP followed by trastuzumab emtansine and pertuzumab (T DM1+P), and T DM1+P in HER2 positive primary breast cancer Breast Cancer Research and Treatment Breast Cancer Research and Treatment Breast Cancer Research and Treatment 2019 有 公開
Kawashima M, Tokiwa M, Nishimura T, Kawata Y, Sugimoto M, Kataoka T, Sakurai T, Iwaisako K, Suzuki E, Hagiwara M, Harris A, Toi M Kawashima M, Tokiwa M, Nishimura T, Kawata Y, Sugimoto M, Kataoka T, Sakurai T, Iwaisako K, Suzuki E, Hagiwara M, Harris A, Toi M Eizi Suzuki High-resolution imaging mass spectrometry combined with transcriptomic analysis identified a link between fatty acid composition of phosphatidylinositols and the immune checkpoint pathway at the primary tumour site of breast cancer High-resolution imaging mass spectrometry combined with transcriptomic analysis identified a link between fatty acid composition of phosphatidylinositols and the immune checkpoint pathway at the primary tumour site of breast cancer High-resolution imaging mass spectrometry combined with transcriptomic analysis identified a link between fatty acid composition of phosphatidylinositols and the immune checkpoint pathway at the primary tumour site of breast cancer British Journal of Cancer British Journal of Cancer British Journal of Cancer 2019 有 公開
Ono Y, Yoshimura M, Hirata K, Yamauchi C, Toi M, Suzuki E, Takada M, Hiraoka M, Mizowaki T Ono Y, Yoshimura M, Hirata K, Yamauchi C, Toi M, Suzuki E, Takada M, Hiraoka M, Mizowaki T Eizi Suzuki The impact of age on the risk of ipsilateral breast tumor recurrence after breastconserving therapy in breast cancer patients with a > 5 mm margin treated without boost irradiation The impact of age on the risk of ipsilateral breast tumor recurrence after breastconserving therapy in breast cancer patients with a > 5 mm margin treated without boost irradiation The impact of age on the risk of ipsilateral breast tumor recurrence after breastconserving therapy in breast cancer patients with a > 5 mm margin treated without boost irradiation Radiation Oncology Radiation Oncology Radiation Oncology 2019 有 公開
Uchida M, Sugie C, Yoshimura M, Suzuki E, Shibamoto Y, Hiraoka M, Akechi T Uchida M, Sugie C, Yoshimura M, Suzuki E, Shibamoto Y, Hiraoka M, Akechi T Eizi Suzuki Factors associated with a preference for disclosure of life expectancy information from physicians: a cross-sectional survey of cancer patients undergoing radiation therapy Factors associated with a preference for disclosure of life expectancy information from physicians: a cross-sectional survey of cancer patients undergoing radiation therapy Factors associated with a preference for disclosure of life expectancy information from physicians: a cross-sectional survey of cancer patients undergoing radiation therapy Support Care Cancer Support Care Cancer Support Care Cancer 2019 有 公開
Kawaguchi K, Sakurai M, Yamamoto Y, Suzuki E, Tsuda M, Kataoka TR, Hirata M, Nishie M, Nojiri T, Kumazoe M, Saito K, Toi M Kawaguchi K, Sakurai M, Yamamoto Y, Suzuki E, Tsuda M, Kataoka TR, Hirata M, Nishie M, Nojiri T, Kumazoe M, Saito K, Toi M Suzuki E Alteration of specific cytokine expression patterns with breast cancer Alteration of specific cytokine expression patterns with breast cancer Alteration of specific cytokine expression patterns with breast cancer Sci Rep Sci Rep 2019 有 公開
Suzuki E, Sugimoto M, Kawaguchi K, Pu F, Uozumi R, Yamaguchi A, Nishie M, Tsuda M, Kotake T, Morita S, Toi M Suzuki E, Sugimoto M, Kawaguchi K, Pu F, Uozumi R, Yamaguchi A, Nishie M, Tsuda M, Kotake T, Morita S, Toi M Suzuki E Gene expression profile of peripheral blood mononuclear cells may contribute to the identification and immunological classification of breast cancer patients Gene expression profile of peripheral blood mononuclear cells may contribute to the identification and immunological classification of breast cancer patients Gene expression profile of peripheral blood mononuclear cells may contribute to the identification and immunological classification of breast cancer patients Breast Cancer Breast Cancer Breast Cancer 2018 有 英語 公開
Sugie T, Suzuki E, Yamauchi A, Yamagami K, Masuda N, Gondo N, Sumi E, Ikeda T, Tada H, Uozumi R, Kanao S, Tanaka T, Hamazaki Y, Minato N, Toi M Sugie T, Suzuki E, Yamauchi A, Yamagami K, Masuda N, Gondo N, Sumi E, Ikeda T, Tada H, Uozumi R, Kanao S, Tanaka T, Hamazaki Y, Minato N, Toi M Sugie T, Suzuki E, Yamauchi A, Yamagami K, Masuda N, Gondo N, Sumi E, Ikeda T, Tada H, Uozumi R, Kanao S, Tanaka T, Hamazaki Y, Minato N, Toi M Combined effects of neoadjuvant letrozole and zoledronic acid on gdT cells in postmenopausal women with early-stage breast cancer Combined effects of neoadjuvant letrozole and zoledronic acid on gdT cells in postmenopausal women with early-stage breast cancer Combined effects of neoadjuvant letrozole and zoledronic acid on gdT cells in postmenopausal women with early-stage breast cancer The Breast The Breast The Breast 2018 有 公開
Mackenzie L, Carey M, Suzuki E, Yoshimura M, Toi M, D'Este C, Sanson-Fisher R Mackenzie L, Carey M, Suzuki E, Yoshimura M, Toi M, D'Este C, Sanson-Fisher R Mackenzie L, Carey M, Suzuki E, Yoshimura M, Toi M, D'Este C, Sanson-Fisher R A cross sectional study of agreement between the Hospital Anxiety and Depression Scale, patient- and radiation oncologist-reported single-item assessment of depression and anxiety A cross sectional study of agreement between the Hospital Anxiety and Depression Scale, patient- and radiation oncologist-reported single-item assessment of depression and anxiety A cross sectional study of agreement between the Hospital Anxiety and Depression Scale, patient- and radiation oncologist-reported single-item assessment of depression and anxiety Psychooncology Psychooncology Psychooncology 2018 有 公開
Takada M, Takeuchi M, Suzuki E, Sato F, Matsumoto Y, Torii M, Kawaguchi-Sakita N, Nishino H, Seo S, Hatano E, Toi M Takada M, Takeuchi M, Suzuki E, Sato F, Matsumoto Y, Torii M, Kawaguchi-Sakita N, Nishino H, Seo S, Hatano E, Toi M Takada M, Takeuchi M, Suzuki E, Sato F, Matsumoto Y, Torii M, Kawaguchi-Sakita N, Nishino H, Seo S, Hatano E, Toi M Real-time navigation system for sentinel lymph node biopsy in breast cancer patients using projection mapping with indocyanine green fluorescence Real-time navigation system for sentinel lymph node biopsy in breast cancer patients using projection mapping with indocyanine green fluorescence Real-time navigation system for sentinel lymph node biopsy in breast cancer patients using projection mapping with indocyanine green fluorescence Breast Cancer Breast Cancer Breast Cancer 2018 有 公開
Mackenzie L, Carey ML, Suzuki E, Sanson-Fisher RW, Asada H, Ogura M, D’Este C, Yoshimura M, Toi M Mackenzie L, Carey ML, Suzuki E, Sanson-Fisher RW, Asada H, Ogura M, D’Este C, Yoshimura M, Toi M Mackenzie L, Carey ML, Suzuki E, Sanson-Fisher RW, Asada H, Ogura M, D’Este C, Yoshimura M, Toi M Agreement between patients’ and radiation oncologists’ cancer diagnosis and prognosis perceptions: A cross sectional study in Japan Agreement between patients’ and radiation oncologists’ cancer diagnosis and prognosis perceptions: A cross sectional study in Japan Agreement between patients’ and radiation oncologists’ cancer diagnosis and prognosis perceptions: A cross sectional study in Japan PLoS One PLoS One PLoS One 2018 有 公開
Matlung HL, Babes L, Zhao XW, van Houdt M, Treffers LW, van Rees DJ, Szilagyi K, Schornagel K, Janssen H, Halonen P, Lieftink C, Beijersbergen RL, Leusen JHW, Boelens JJ, Kuhnle I, Van Der Werff Ten, Bosch J, Seeger K, Rutella S, Pagliara D, Matozaki T, Suzuki E, Menke-van der Houven, van Oordt CW, van Bruggen R, Roos D, van Lier RAW, Kuijpers TW, Kubes P, van den Berg TK Matlung HL, Babes L, Zhao XW, van Houdt M, Treffers LW, van Rees DJ, Szilagyi K, Schornagel K, Janssen H, Halonen P, Lieftink C, Beijersbergen RL, Leusen JHW, Boelens JJ, Kuhnle I, Van Der Werff Ten, Bosch J, Seeger K, Rutella S, Pagliara D, Matozaki T, Suzuki E, Menke-van der Houven, van Oordt CW, van Bruggen R, Roos D, van Lier RAW, Kuijpers TW, Kubes P, van den Berg TK Matlung HL, Babes L, Zhao XW, van Houdt M, Treffers LW, van Rees DJ, Szilagyi K, Schornagel K, Janssen H, Halonen P, Lieftink C, Beijersbergen RL, Leusen JHW, Boelens JJ, Kuhnle I, Van Der Werff Ten, Bosch J, Seeger K, Rutella S, Pagliara D, Matozaki T, Suzuki E, Menke-van der Houven, van Oordt CW, van Bruggen R, Roos D, van Lier RAW, Kuijpers TW, Kubes P, van den Berg TK Neutrophils kill antibody-opsonized cancer cells by trogoptosis Neutrophils kill antibody-opsonized cancer cells by trogoptosis Neutrophils kill antibody-opsonized cancer cells by trogoptosis Cell Rep Cell Rep Cell Rep 2018 有 公開
Kawaguchi K, Suzuki E, Nishie M, Kii I, Kataoka TR, Hirata M, Inoue M, Pu F, Iwaisako K, Tsuda M, Yamaguchi A, Haga H, Hagiwara M, Toi M Kawaguchi K, Suzuki E, Nishie M, Kii I, Kataoka TR, Hirata M, Inoue M, Pu F, Iwaisako K, Tsuda M, Yamaguchi A, Haga H, Hagiwara M, Toi M Kawaguchi K, Suzuki E, Nishie M, Kii I, Kataoka TR, Hirata M, Inoue M, Pu F, Iwaisako K, Tsuda M, Yamaguchi A, Haga H, Hagiwara M, Toi M Downregulation of neuropilin-1 on macrophages modulates antibody-mediated tumoricidal activity Downregulation of neuropilin-1 on macrophages modulates antibody-mediated tumoricidal activity Downregulation of neuropilin-1 on macrophages modulates antibody-mediated tumoricidal activity Cancer Immunol Immunother Cancer Immunol Immunother Cancer Immunol Immunother 2017 有 公開
Kawaguchi K, Suzuki E, Yamaguchi A, Yamamoto M, Morita S, Toi M Kawaguchi K, Suzuki E, Yamaguchi A, Yamamoto M, Morita S, Toi M Kawaguchi K, Suzuki E, Yamaguchi A, Yamamoto M, Morita S, Toi M Altered expression of major immune regulatory molecules in peripheral blood immune cells associated with breast cancer Altered expression of major immune regulatory molecules in peripheral blood immune cells associated with breast cancer Altered expression of major immune regulatory molecules in peripheral blood immune cells associated with breast cancer Breast Cancer Breast Cancer Breast Cancer 2016 有 公開
Hirata K, Yoshimura M, Inoue M, Yamauchi C, Orura M, Toi M, Suzuki E, Takeuchi M, Takada M, Hiraoka M Hirata K, Yoshimura M, Inoue M, Yamauchi C, Orura M, Toi M, Suzuki E, Takeuchi M, Takada M, Hiraoka M Hirata K, Yoshimura M, Inoue M, Yamauchi C, Orura M, Toi M, Suzuki E, Takeuchi M, Takada M, Hiraoka M Regional recurrence in breast cancer patients with one to three positive axillary lymph nodes treated with breast-conserving surgery and whole breast irradiation Regional recurrence in breast cancer patients with one to three positive axillary lymph nodes treated with breast-conserving surgery and whole breast irradiation Regional recurrence in breast cancer patients with one to three positive axillary lymph nodes treated with breast-conserving surgery and whole breast irradiation Journal of Radiation Research Journal of Radiation Research Journal of Radiation Research 2016 有 公開
Ueshima C, Kataoka TR, Hirata M, Furuhata A, Suzuki E, Toi M, Tsuruyama T, Okayama Y, Haga H Ueshima C, Kataoka TR, Hirata M, Furuhata A, Suzuki E, Toi M, Tsuruyama T, Okayama Y, Haga H Ueshima C, Kataoka TR, Hirata M, Furuhata A, Suzuki E, Toi M, Tsuruyama T, Okayama Y, Haga H The killer cell Ig-like receptor 2DL4 expression in human mast cells and its potential role in breast cancer invasion The killer cell Ig-like receptor 2DL4 expression in human mast cells and its potential role in breast cancer invasion The killer cell Ig-like receptor 2DL4 expression in human mast cells and its potential role in breast cancer invasion Cancer Immunol Res Cancer Immunol Res Cancer Immunol Res 2015 有 公開
Suzuki E, Mackenzie L, Sanson-Fisher R, Carey M, D'Este C, Asada H, Toi M Suzuki E, Mackenzie L, Sanson-Fisher R, Carey M, D'Este C, Asada H, Toi M Suzuki E, Mackenzie L, Sanson-Fisher R, Carey M, D'Este C, Asada H, Toi M Acceptability of a Touch Screen Tablet Psychosocial Survey Administered to Radiation Therapy Patients in Japan Acceptability of a Touch Screen Tablet Psychosocial Survey Administered to Radiation Therapy Patients in Japan Acceptability of a Touch Screen Tablet Psychosocial Survey Administered to Radiation Therapy Patients in Japan Int J Behav Med Int J Behav Med Int J Behav Med 2015 有 公開
Suzuki E, Kataoka T, Hirata M, Kawaguchi K, Nishie M, Haga H, Toi M Suzuki E, Kataoka T, Hirata M, Kawaguchi K, Nishie M, Haga H, Toi M Suzuki E, Kataoka T, Hirata M, Kawaguchi K, Nishie M, Haga H, Toi M Trogocytosis-mediated expression of HER2 on immune cells may be associated with a pathological complete response to trastuzumab-based primary systemic therapy in HER2-overexpressing breast cancer patients Trogocytosis-mediated expression of HER2 on immune cells may be associated with a pathological complete response to trastuzumab-based primary systemic therapy in HER2-overexpressing breast cancer patients Trogocytosis-mediated expression of HER2 on immune cells may be associated with a pathological complete response to trastuzumab-based primary systemic therapy in HER2-overexpressing breast cancer patients BMC Cancer BMC Cancer BMC Cancer 2015 有 公開
Kawaguchi-Sakita N, Kaneshiro-Nakagawa K, Kawashima M, Sugimoto M, Tokiwa M, Suzuki E, Kajihara S, Fujita Y, Iwamoto S, Tanaka K, Toi M Kawaguchi-Sakita N, Kaneshiro-Nakagawa K, Kawashima M, Sugimoto M, Tokiwa M, Suzuki E, Kajihara S, Fujita Y, Iwamoto S, Tanaka K, Toi M Kawaguchi-Sakita N, Kaneshiro-Nakagawa K, Kawashima M, Sugimoto M, Tokiwa M, Suzuki E, Kajihara S, Fujita Y, Iwamoto S, Tanaka K, Toi M Serum immunoglobulin G Fc region N-glycosylation profiling by matrix-assisted laser desorption/ionization mass spectrometry can distinguish breast cancer patients from cancer-free controls Serum immunoglobulin G Fc region N-glycosylation profiling by matrix-assisted laser desorption/ionization mass spectrometry can distinguish breast cancer patients from cancer-free controls Serum immunoglobulin G Fc region N-glycosylation profiling by matrix-assisted laser desorption/ionization mass spectrometry can distinguish breast cancer patients from cancer-free controls Biochem Biophys Res Commun Biochem Biophys Res Commun Biochem Biophys Res Commun 2015 有 公開
Sumi E, Sugie T, Yoshimura K, Tada H, Ikeda T, Suzuki E, Tanaka Y, Teramukai S, Shimizu A, Toi M, Minato N Sumi E, Sugie T, Yoshimura K, Tada H, Ikeda T, Suzuki E, Tanaka Y, Teramukai S, Shimizu A, Toi M, Minato N Sumi E, Sugie T, Yoshimura K, Tada H, Ikeda T, Suzuki E, Tanaka Y, Teramukai S, Shimizu A, Toi M, Minato N Effects of zoledronic acid and the association between its efficacy and γδT cells in postmenopausal women with breast cancer treated with preoperative hormonal therapy: a study protocol Effects of zoledronic acid and the association between its efficacy and γδT cells in postmenopausal women with breast cancer treated with preoperative hormonal therapy: a study protocol Effects of zoledronic acid and the association between its efficacy and γδT cells in postmenopausal women with breast cancer treated with preoperative hormonal therapy: a study protocol J Transl Med J Transl Med J Transl Med 2014 有 公開
Quatromoni JG, Suzuki E, Okusanya O, Judy BF, Bhojnagarwala P, Venegas O, Eruslanov E, Predina JD, Albelda SM, Singhal S Quatromoni JG, Suzuki E, Okusanya O, Judy BF, Bhojnagarwala P, Venegas O, Eruslanov E, Predina JD, Albelda SM, Singhal S Quatromoni JG, Suzuki E, Okusanya O, Judy BF, Bhojnagarwala P, Venegas O, Eruslanov E, Predina JD, Albelda SM, Singhal S The timing of TGF-beta inhibition affects the generation of antigen-specific CD8+ T Cells. The timing of TGF-beta inhibition affects the generation of antigen-specific CD8+ T Cells. The timing of TGF-beta inhibition affects the generation of antigen-specific CD8+ T Cells. BMC Immunol BMC Immunol BMC Immunol 2013 有 公開
Honda M, Saji S, Horiguchi S, Suzuki E, Aruga T, Horiguchi K, Kitagawa D, Sekine S, Funata N, Toi M, Kuroi K Honda M, Saji S, Horiguchi S, Suzuki E, Aruga T, Horiguchi K, Kitagawa D, Sekine S, Funata N, Toi M, Kuroi K Honda M, Saji S, Horiguchi S, Suzuki E, Aruga T, Horiguchi K, Kitagawa D, Sekine S, Funata N, Toi M, Kuroi K Clinicopathological analysis of ten patients with metaplastic squamous cell carcinoma of the breast. Clinicopathological analysis of ten patients with metaplastic squamous cell carcinoma of the breast. Clinicopathological analysis of ten patients with metaplastic squamous cell carcinoma of the breast. Surg Today Surg Today Surg Today 2011 有 公開
Han HS, Reis IM, Zhao W, Kuroi K, Toi M, Suzuki E, Syme R, Chow L, Yip AY, Glück S Han HS, Reis IM, Zhao W, Kuroi K, Toi M, Suzuki E, Syme R, Chow L, Yip AY, Glück S Han HS, Reis IM, Zhao W, Kuroi K, Toi M, Suzuki E, Syme R, Chow L, Yip AY, Glück S Racial differences in acute toxicities of neoadjuvant or adjuvant chemotherapy in patients with early-stage breast cancer. Racial differences in acute toxicities of neoadjuvant or adjuvant chemotherapy in patients with early-stage breast cancer. Racial differences in acute toxicities of neoadjuvant or adjuvant chemotherapy in patients with early-stage breast cancer. Eur J Cancer Eur J Cancer Eur J Cancer 2011 有 公開
Fridlender ZG, Sun J, Singhal S, Kapoor V, Cheng G, Suzuki E, Albelda SM Fridlender ZG, Sun J, Singhal S, Kapoor V, Cheng G, Suzuki E, Albelda SM Fridlender ZG, Sun J, Singhal S, Kapoor V, Cheng G, Suzuki E, Albelda SM Chemotherapy Delivered After Viral Immunogene Therapy Augments Antitumor Efficacy Via Multiple Immune-mediated Mechanisms. Chemotherapy Delivered After Viral Immunogene Therapy Augments Antitumor Efficacy Via Multiple Immune-mediated Mechanisms. Chemotherapy Delivered After Viral Immunogene Therapy Augments Antitumor Efficacy Via Multiple Immune-mediated Mechanisms. Mol Ther Mol Ther Mol Ther 2010 有 公開
Aruga T, Suzuki E, Saji S, Horiguchi S, Horiguchi K, Sekine S, Kitagawa D, Funata N, Toi M, Sugihara K, Kuroi K Aruga T, Suzuki E, Saji S, Horiguchi S, Horiguchi K, Sekine S, Kitagawa D, Funata N, Toi M, Sugihara K, Kuroi K Aruga T, Suzuki E, Saji S, Horiguchi S, Horiguchi K, Sekine S, Kitagawa D, Funata N, Toi M, Sugihara K, Kuroi K A low number of tumor-infiltrating FOXP3-positive cells during primary systemic chemotherapy correlates with favorable anti-tumor response in patients with breast cancer A low number of tumor-infiltrating FOXP3-positive cells during primary systemic chemotherapy correlates with favorable anti-tumor response in patients with breast cancer A low number of tumor-infiltrating FOXP3-positive cells during primary systemic chemotherapy correlates with favorable anti-tumor response in patients with breast cancer Oncol Rep Oncol Rep Oncol Rep 2009 有 公開
Muta M, Yanagawa T, Sai Y, Saji S, Suzuki E, Aruga T, Kuroi K, Matsumoto G, Toi M, Nakashima E Muta M, Yanagawa T, Sai Y, Saji S, Suzuki E, Aruga T, Kuroi K, Matsumoto G, Toi M, Nakashima E Muta M, Yanagawa T, Sai Y, Saji S, Suzuki E, Aruga T, Kuroi K, Matsumoto G, Toi M, Nakashima E Effect of Low-Dose Paclitaxel and Docetaxel on Endothelial Progenitor Cells Effect of Low-Dose Paclitaxel and Docetaxel on Endothelial Progenitor Cells Effect of Low-Dose Paclitaxel and Docetaxel on Endothelial Progenitor Cells Oncology Oncology Oncology 2009 有 公開
Nakamura S, Yagata H, Ohno S, Yamaguchi H, Iwata H, Tsunoda N, Ito Y, Tokudome N, Toi M, Kuroi K, Suzuki E Nakamura S, Yagata H, Ohno S, Yamaguchi H, Iwata H, Tsunoda N, Ito Y, Tokudome N, Toi M, Kuroi K, Suzuki E Nakamura S, Yagata H, Ohno S, Yamaguchi H, Iwata H, Tsunoda N, Ito Y, Tokudome N, Toi M, Kuroi K, Suzuki E Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer Breast Cancer Breast Cancer Breast Cancer 2009 有 公開
Suzuki E, Kim S, Cheung HK, Corbley MJ, Zhang X, Sun L, Shan F, Singh J, Lee WC, Albelda SM, Ling LE Suzuki E, Kim S, Cheung HK, Corbley MJ, Zhang X, Sun L, Shan F, Singh J, Lee WC, Albelda SM, Ling LE Suzuki E, Kim S, Cheung HK, Corbley MJ, Zhang X, Sun L, Shan F, Singh J, Lee WC, Albelda SM, Ling LE A novel small-molecule inhibitor of transforming growth factor beta type I receptor kinase (SM16) inhibits murine mesothelioma tumor growth in vivo and prevents tumor recurrence after surgical resection A novel small-molecule inhibitor of transforming growth factor beta type I receptor kinase (SM16) inhibits murine mesothelioma tumor growth in vivo and prevents tumor recurrence after surgical resection A novel small-molecule inhibitor of transforming growth factor beta type I receptor kinase (SM16) inhibits murine mesothelioma tumor growth in vivo and prevents tumor recurrence after surgical resection Cancer Res Cancer Res Cancer Res 2007 有 公開
Suzuki E, Niwa R, Saji S, Muta M, Hirose M, Iida S, Shiotsu Y, Satoh M, Shitara K, Kondo M, Toi M Suzuki E, Niwa R, Saji S, Muta M, Hirose M, Iida S, Shiotsu Y, Satoh M, Shitara K, Kondo M, Toi M Suzuki E, Niwa R, Saji S, Muta M, Hirose M, Iida S, Shiotsu Y, Satoh M, Shitara K, Kondo M, Toi M A nonfucosylated anti-HER2 antibody augments antibody-dependent cellular cytotoxicity in breast cancer patients A nonfucosylated anti-HER2 antibody augments antibody-dependent cellular cytotoxicity in breast cancer patients A nonfucosylated anti-HER2 antibody augments antibody-dependent cellular cytotoxicity in breast cancer patients Clin Cancer Res Clin Cancer Res Clin Cancer Res 2007 有 公開
Suzuki E, Toi M Suzuki E, Toi M Suzuki E, Toi M mproving the efficacy of trastuzumab in breast cancer mproving the efficacy of trastuzumab in breast cancer mproving the efficacy of trastuzumab in breast cancer Cancer Sci Cancer Sci Cancer Sci 2007 有 公開
Suzuki E, Sun J, Kapoor V, Jassar AS, Albelda SM Suzuki E, Sun J, Kapoor V, Jassar AS, Albelda SM Suzuki E, Sun J, Kapoor V, Jassar AS, Albelda SM Gemcitabine Has Significant Immunomodulatory Activity in Murine Tumor Models Independent of its Cytotoxic Effects Gemcitabine Has Significant Immunomodulatory Activity in Murine Tumor Models Independent of its Cytotoxic Effects Gemcitabine Has Significant Immunomodulatory Activity in Murine Tumor Models Independent of its Cytotoxic Effects Cancer Biol Ther Cancer Biol Ther Cancer Biol Ther 2007 有 公開
Wilderman, M, Sun, J, Khan, M, Vachani, A, Suzuki E, Kinnery, P, Steman, D, Kaiser, L, Albelda, S.M Wilderman, M, Sun, J, Khan, M, Vachani, A, Suzuki E, Kinnery, P, Steman, D, Kaiser, L, Albelda, S.M Wilderman, M, Sun, J, Khan, M, Vachani, A, Suzuki E, Kinnery, P, Steman, D, Kaiser, L, Albelda, S.M Intrapulmonary interferon-beta gene therapy using an adenoviral vector is highly effective in a murine orthotopic model of lung adenocarcinoma via a combination of direct toxicity, NK cell, and CD8 T-cell mediated effects Intrapulmonary interferon-beta gene therapy using an adenoviral vector is highly effective in a murine orthotopic model of lung adenocarcinoma via a combination of direct toxicity, NK cell, and CD8 T-cell mediated effects Intrapulmonary interferon-beta gene therapy using an adenoviral vector is highly effective in a murine orthotopic model of lung adenocarcinoma via a combination of direct toxicity, NK cell, and CD8 T-cell mediated effects Cancer Research Cancer Research Cancer Research 2005 有 公開
Suzuki E, Kapoor, V, Jassar, A, Kaiser, LR, Albelda, S.M Suzuki E, Kapoor, V, Jassar, A, Kaiser, LR, Albelda, S.M Suzuki E, Kapoor, V, Jassar, A, Kaiser, LR, Albelda, S.M Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances anti-tumor immune activity Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances anti-tumor immune activity Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances anti-tumor immune activity Clinical Cancer Research Clinical Cancer Research Clinical Cancer Research 2005 有 公開
Jassar, A, Suzuki E, Kapoor, V, Sun, J, Silverberg, M, Cheung, L, Burdick, M, Strieter, R, Ching, L-M, Kaiser, L.R, Albelda, S.M Jassar, A, Suzuki E, Kapoor, V, Sun, J, Silverberg, M, Cheung, L, Burdick, M, Strieter, R, Ching, L-M, Kaiser, L.R, Albelda, S.M Jassar, A, Suzuki E, Kapoor, V, Sun, J, Silverberg, M, Cheung, L, Burdick, M, Strieter, R, Ching, L-M, Kaiser, L.R, Albelda, S.M Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma Cancer Res Cancer Res Cancer Res 2005 有 公開
Matsuoka K, Tsukuda K, Suda M, Kobayashi K, Ota T, Okita A, Watanabe K, Suzuki E, Murakami M, Doihara H, Shimizu N Matsuoka K, Tsukuda K, Suda M, Kobayashi K, Ota T, Okita A, Watanabe K, Suzuki E, Murakami M, Doihara H, Shimizu N Matsuoka K, Tsukuda K, Suda M, Kobayashi K, Ota T, Okita A, Watanabe K, Suzuki E, Murakami M, Doihara H, Shimizu N The transfection of thymidylate synthase antisense suppresses oncogenic properties of a human colon cancer cell line and augments the antitumor effect of fluorouracil The transfection of thymidylate synthase antisense suppresses oncogenic properties of a human colon cancer cell line and augments the antitumor effect of fluorouracil The transfection of thymidylate synthase antisense suppresses oncogenic properties of a human colon cancer cell line and augments the antitumor effect of fluorouracil Int J Oncol Int J Oncol Int J Oncol 2004 有 公開
Suzuki E, Ota T, Tsukuda K, Okita A, Matsuoka K, Murakami M, Doihara H, Shimizu N Suzuki E, Ota T, Tsukuda K, Okita A, Matsuoka K, Murakami M, Doihara H, Shimizu N Suzuki E, Ota T, Tsukuda K, Okita A, Matsuoka K, Murakami M, Doihara H, Shimizu N nm23-H1 reduces in vitro cell migration and the liver metastatic potential of colon cancer cells by regulating myosin light chain phosphorylation nm23-H1 reduces in vitro cell migration and the liver metastatic potential of colon cancer cells by regulating myosin light chain phosphorylation nm23-H1 reduces in vitro cell migration and the liver metastatic potential of colon cancer cells by regulating myosin light chain phosphorylation Int J Cancer Int J Cancer Int J Cancer 2004 有 学位論文(博士) 公開
Suzuki E, Kapoor V, Cheung HK, Ling LE, DeLong PA, Kaiser LR, Albelda SM Suzuki E, Kapoor V, Cheung HK, Ling LE, DeLong PA, Kaiser LR, Albelda SM Suzuki E, Kapoor V, Cheung HK, Ling LE, DeLong PA, Kaiser LR, Albelda SM Soluble type II transforming growth factor-beta receptor inhibits established murine malignant mesothelioma tumor growth by augmenting host antitumor immunity Soluble type II transforming growth factor-beta receptor inhibits established murine malignant mesothelioma tumor growth by augmenting host antitumor immunity Soluble type II transforming growth factor-beta receptor inhibits established murine malignant mesothelioma tumor growth by augmenting host antitumor immunity Clin Cancer Res Clin Cancer Res Clin Cancer Res 2004 有 公開

  • <<
  • >>
  • 表示
タイトル言語:
講演・口頭発表等
タイトル タイトル(日本語) タイトル(英語) 会議名 会議名(日本語) 会議名(英語) 主催者 主催者(日本語) 主催者(英語) 開催年月日 記述言語 会議種別 公開
Exploration of metastatic brain tumor microenvironment specific molecular properties of immune cells and breast cancer cells Exploration of metastatic brain tumor microenvironment specific molecular properties of immune cells and breast cancer cells Exploration of metastatic brain tumor microenvironment specific molecular properties of immune cells and breast cancer cells 2nd Annual Advancing CNS Biotherapeutics and Crossing the Blood-Brain Barrier 2nd Annual Advancing CNS Biotherapeutics and Crossing the Blood-Brain Barrier 2nd Annual Advancing CNS Biotherapeutics and Crossing the Blood-Brain Barrier 2019/01 英語 口頭発表(一般) 公開
Patritumab (anti-HER3 antibody) augments anti-tumor immune response of adoptive transfer of autologous activated T cells for patient-derived xenograft models of breast cancer Patritumab (anti-HER3 antibody) augments anti-tumor immune response of adoptive transfer of autologous activated T cells for patient-derived xenograft models of breast cancer Patritumab (anti-HER3 antibody) augments anti-tumor immune response of adoptive transfer of autologous activated T cells for patient-derived xenograft models of breast cancer ESMO ESMO ESMO 2018 英語 ポスター発表 公開
Potential role of lipid metabolic network related to anti-tumor immune response in breast cancer microenvironment Potential role of lipid metabolic network related to anti-tumor immune response in breast cancer microenvironment Potential role of lipid metabolic network related to anti-tumor immune response in breast cancer microenvironment Cell Symposia Cell Symposia Cell Symposia 2018 公開
HER2陽性乳癌治療戦略における治療効果／耐性メカニズムの免疫学的意義[招待あり] HER2陽性乳癌治療戦略における治療効果／耐性メカニズムの免疫学的意義 [招待あり] HER2陽性乳癌治療戦略における治療効果／耐性メカニズムの免疫学的意義 [招待あり] 第26回日本乳癌学会学術総会ワークショップ 第26回日本乳癌学会学術総会ワークショップ 2018 公開
Gene expression profile of peripheral blood mononuclear cells in breast cancer patients may contribute to the identification and the immunological classification of breast cancer patients by blood test Gene expression profile of peripheral blood mononuclear cells in breast cancer patients may contribute to the identification and the immunological classification of breast cancer patients by blood test Gene expression profile of peripheral blood mononuclear cells in breast cancer patients may contribute to the identification and the immunological classification of breast cancer patients by blood test AACR AACR AACR 2017 公開
Proteomics analysis of breast cancer cell-specific proteins that are transferred to immune cells via trogocytosis Proteomics analysis of breast cancer cell-specific proteins that are transferred to immune cells via trogocytosis Proteomics analysis of breast cancer cell-specific proteins that are transferred to immune cells via trogocytosis AACR AACR AACR 2016 公開
EGFR is transferred from triple negative breast cancer cells to immune cells via trogocytosis and expression of EGFR on immune cells is associated with high tumor grade of triple negative breast cancer patients EGFR is transferred from triple negative breast cancer cells to immune cells via trogocytosis and expression of EGFR on immune cells is associated with high tumor grade of triple negative breast cancer patients EGFR is transferred from triple negative breast cancer cells to immune cells via trogocytosis and expression of EGFR on immune cells is associated with high tumor grade of triple negative breast cancer patients AACR AACR AACR 2015 公開
A role of trogocytosis of immune cells in breast tumor microenvironment[招待あり] A role of trogocytosis of immune cells in breast tumor microenvironment [招待あり] A role of trogocytosis of immune cells in breast tumor microenvironment [招待あり] 20th World Congress on Advances in Oncology and 18th International Symposium on Molecular Medicine 20th World Congress on Advances in Oncology and 18th International Symposium on Molecular Medicine 20th World Congress on Advances in Oncology and 18th International Symposium on Molecular Medicine 2015 公開
Loss of HER2 via trogocytosis by CD14+ cells in HER2 overexpressing breast cancer cells are associated with diminishing of trastuzumab mediated antibody dependent cellular cytotoxicity Loss of HER2 via trogocytosis by CD14+ cells in HER2 overexpressing breast cancer cells are associated with diminishing of trastuzumab mediated antibody dependent cellular cytotoxicity Loss of HER2 via trogocytosis by CD14+ cells in HER2 overexpressing breast cancer cells are associated with diminishing of trastuzumab mediated antibody dependent cellular cytotoxicity AACR AACR AACR 2014 公開
Upregulation of neuropilin-1 in human monocyte is induced by RANKL and may be associated with trastuzumab mediated antibody dependent cellular cytotoxicity in breast cancer cells Upregulation of neuropilin-1 in human monocyte is induced by RANKL and may be associated with trastuzumab mediated antibody dependent cellular cytotoxicity in breast cancer cells Upregulation of neuropilin-1 in human monocyte is induced by RANKL and may be associated with trastuzumab mediated antibody dependent cellular cytotoxicity in breast cancer cells AACR AACR AACR 2013 公開
Acceptability of touch screen computer psychosocial survey to Japanese radiation therapy patients Acceptability of touch screen computer psychosocial survey to Japanese radiation therapy patients Acceptability of touch screen computer psychosocial survey to Japanese radiation therapy patients COSA 39th Annual Scientific Meeting and IPOS 14th World Congress of Psycho-Oncology COSA 39th Annual Scientific Meeting and IPOS 14th World Congress of Psycho-Oncology COSA 39th Annual Scientific Meeting and IPOS 14th World Congress of Psycho-Oncology 2012 公開
bility of serum vascular endothelial growth factor in advanced or metastatic colorectal cancer patients to inhibit lymphokine activated killer cells bility of serum vascular endothelial growth factor in advanced or metastatic colorectal cancer patients to inhibit lymphokine activated killer cells bility of serum vascular endothelial growth factor in advanced or metastatic colorectal cancer patients to inhibit lymphokine activated killer cells AACR AACR AACR 2011 公開
Serum vascular endothelial growth factor in advanced breast cancer patients might be a key role of inhibitory effect on lymphokine activated killer cells Serum vascular endothelial growth factor in advanced breast cancer patients might be a key role of inhibitory effect on lymphokine activated killer cells Serum vascular endothelial growth factor in advanced breast cancer patients might be a key role of inhibitory effect on lymphokine activated killer cells AACR AACR AACR 2010 公開
Serum from breast cancer patients shows either augmentation or inhibition of lymphokine activated killer cells against human breast cancer cell line Serum from breast cancer patients shows either augmentation or inhibition of lymphokine activated killer cells against human breast cancer cell line Serum from breast cancer patients shows either augmentation or inhibition of lymphokine activated killer cells against human breast cancer cell line AACR AACR AACR 2008 公開

  • <<
  • >>
  • 表示
タイトル言語:
書籍等出版物
著者 著者(日本語) 著者(英語) タイトル タイトル(日本語) タイトル(英語) 出版社 出版社(日本語) 出版社(英語) 出版年月 記述言語 担当区分 公開
Eiji Suzuki, Steven M. Albelda Eiji Suzuki, Steven M. Albelda Eiji Suzuki, Steven M. Albelda Soluble Type II Transforming Growth Factor-b Receptor Inhibits Tumorigenesis by Augmenting Host Antitumor Immunity Soluble Type II Transforming Growth Factor-b Receptor Inhibits Tumorigenesis by Augmenting Host Antitumor Immunity Soluble Type II Transforming Growth Factor-b Receptor Inhibits Tumorigenesis by Augmenting Host Antitumor Immunity 公開
タイトル言語:
外部資金：競争的資金 (科学研究費補助金)
種別 代表/分担 テーマ(日本語) テーマ(英語) 期間
基盤研究（Ｃ） 代表 乳癌に対するトラスツズマブ効果予測因子としてのニューロピリン1陽性免疫細胞の意義 2013〜2015
基盤研究（Ｃ） 代表 乳癌に対するトラスツズマブ効果予測因子としてのニューロピリン1陽性免疫細胞の意義 （平成26年度分） 2014/04/01〜2015/03/31
基盤研究（Ｃ） 代表 乳癌に対するトラスツズマブ効果予測因子としてのニューロピリン1陽性免疫細胞の意義 （平成27年度分） 2015/04/01〜2016/03/31
基盤研究(C) 代表 乳癌微小環境におけるマクロファージの脳転移特異的な役割の解明 （平成29年度分） 2017/04/01〜2018/03/31
基盤研究(C) 代表 乳癌微小環境におけるマクロファージの脳転移特異的な役割の解明 （平成30年度分） 2018/04/01〜2019/03/31
担当科目
講義名(日本語) 講義名(英語) 開講期 学部/研究科 年度
臨床外科疾病論Ⅱ Clinical Overview of Surgery II 後期 医学部（人間健康科学科） 2014/04〜2015/03
臨床外科疾病論Ⅱ Clinical Overview of Surgery II 後期 医学部（人間健康科学科） 2015/04〜2016/03
臨床外科疾病論Ⅱ Clinical Overview of Surgery II 後期 医学部（人間健康科学科） 2016/04〜2017/03
臨床外科疾病論Ⅱ Clinical Overview of Surgery II 後期 医学部（人間健康科学科） 2017/04〜2018/03
生殖科学II Reproductive Science II 前期 医学研究科（人間健康科学系専攻） 2018/04〜2019/03
臨床疾病論G Clinical Overview of Medicine G 前期後半 医学部（人間健康科学科） 2019/04〜2020/03
臨床疾病論G Clinical Overview of Medicine G 前期後半 薬学部 2019/04〜2020/03
部局運営（役職等）
役職名 期間
リスクマネージャー会議 委員 2011/04/01〜
病棟医長・看護師長会議 委員 2013/02/01〜

前のページへ戻る

このページのTOPへ